December 2, 2025 19:49 Regulatory Flerie och andra storägare ökar ägandet i Prokarium genom intern finansieringsrunda som minskar rapporterat substansvärde
December 2, 2025 19:49 Regulatory Flerie and other major shareholders increase their ownership in Prokarium through an internal financing that reduces the reported net asset value
August 29, 2025 08:00 Regulatory Förändring av det totala antalet aktier och röster i Flerie AB (publ)
August 8, 2025 15:30 Regulatory The Swedish Companies Registration Office has granted permission to implement the merger plan between Flerie and Toleranzia
August 8, 2025 15:30 Regulatory Bolagsverket har lämnat tillstånd att verkställa fusionsplanen mellan Flerie och Toleranzia
July 31, 2025 09:00 Regulatory The Board of Directors of Flerie has resolved to redeem all Series C shares within the framework of Flerie’s share redemption scheme
July 31, 2025 09:00 Regulatory Styrelsen i Flerie beslutar om inlösen av samtliga aktier av serie C inom ramen för Fleries aktieinlösenprogram
July 16, 2025 08:00 Regulatory Flerie AB:s dotterbolag Flerie Invest AB offentliggör slutligt utfall avseende det kontanta budpliktsbudet till aktieägarna i Nanologica AB (publ)
July 16, 2025 08:00 Regulatory Flerie AB’s subsidiary Flerie Invest AB announces final outcome of the mandatory cash offer to the shareholders of Nanologica AB (publ)
July 1, 2025 08:00 Regulatory Styrelsen i Flerie beslutar om omvandling av stamaktier till aktier av serie C inom ramen för Fleries aktieinlösenprogram
July 1, 2025 08:00 Regulatory The Board of Directors of Flerie has resolved to convert ordinary shares into Series C shares under Flerie’s share redemption scheme
June 16, 2025 10:00 Regulatory Flerie AB:s dotterbolag Flerie Invest AB offentliggör erbjudandehandling avseende det kontanta budpliktsbudet till aktieägarna i Nanologica AB (publ)
June 16, 2025 10:00 Regulatory Flerie AB’s subsidiary Flerie Invest AB publish the offer document for the mandatory cash offer to the shareholders of Nanologica AB (publ)
May 23, 2025 07:30 Regulatory Flerie Invest AB announces a mandatory cash offer to the shareholders of Nanologica AB (publ)
May 23, 2025 07:30 Regulatory Flerie Invest AB lämnar ett kontant budpliktsbud till aktieägarna Nanologica AB (publ)
May 14, 2025 14:00 Regulatory Bolagsstämmorna i Flerie respektive Toleranzia har godkänt fusionsplanen och bolagsstämman i Flerie har beslutat om emission av fusionsvederlaget
May 14, 2025 14:00 Regulatory The General Meetings of Flerie and Toleranzia respectively have approved the merger plan and the General Meeting in Flerie has resolved on issuance of the merger consideration
May 14, 2025 12:30 Regulatory Bulletin from the Annual General Meeting of Flerie AB (publ) on 14 May 2025
April 25, 2025 19:15 Regulatory Flerie har ökat sitt innehav i Nanologica varigenom budplikt uppkommer
April 25, 2025 19:15 Regulatory Flerie has increased its holding in Nanologica, whereby an obligation to make a mandatory bid arises
April 4, 2025 16:12 Regulatory Rättelse: Flerie säljer aktier i Toleranzia till långsiktiga investerare i Flerie
April 4, 2025 16:12 Regulatory Correction: Flerie sells Toleranzia shares to long-term Flerie investors
April 4, 2025 15:30 Regulatory Flerie säljer aktier i Toleranzia till långsiktiga investerare i Flerie
March 25, 2025 10:30 Regulatory Flerie and Toleranzia have agreed on a merger plan to take Toleranzia private
June 26, 2024 16:15 Regulatory Flerie har godkänts för notering på Nasdaq Stockholm och publicerar prospekt
June 26, 2024 16:15 Regulatory Flerie has been approved for listing on Nasdaq Stockholm and publishes its prospectus
June 13, 2024 20:35 Regulatory Flerie carries out a directed share issue of more than SEK 600 million
June 11, 2024 08:00 Regulatory Flerie utreder förutsättningarna för att genomföra en riktad nyemission av stamaktier om upp till cirka 600 miljoner SEK, varav cirka 520 miljoner SEK utgörs av förhandsåtaganden
June 11, 2024 08:00 Regulatory Flerie explores the conditions for carrying out a directed issue of ordinary shares of up to approximately SEK 600 million of which approximately SEK 520 million is pre-committed
June 7, 2024 Regulatory InDex Pharmaceuticals har erhållit villkorat godkännande för fortsatt notering på Nasdaq First North Growth Market efter det omvända förvärvet av Flerie
June 7, 2024 Regulatory InDex Pharmaceuticals has received a conditional approval for continued listing on Nasdaq First North Growth Market after the reverse merger of Flerie
June 5, 2024 Regulatory Rättelse: InDex Pharmaceuticals offentliggör Fleries substansvärde per 31 maj 2024
May 27, 2024 Regulatory InDex Pharmaceuticals publishes company description in connection with the reverse merger of Flerie
May 20, 2024 Regulatory InDex Pharmaceuticals has entered into a conditional agreement regarding a reverse merger with Flerie